MYX vs VIT

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

MYX

M PHARMA FPO [MYX]

48LOW

VIT

VITURA FPO [VIT]

48LOW

Score Breakdown

MYX VIT
Technical
78
64
Catalyst
87
53
Sentiment
50
50
Fundamental
87
93
Momentum
27
34
Risk Gate
45
45

Key Metrics

MYX Metric VIT
$189.7MMarket Cap$25.2M
599KAvg Volume (20d)485K
+2.9%Short InterestN/A
$7.29552-Week High$0.084
$2.04052-Week Low$0.038
+3.8%Daily Change+5.1%
$2.335Entry Price$0.041
-20.6%ROE+1.2%
-20.4%Profit Margin+0.6%

Active Signals

MYX Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Volume surging at 2.8x normal while price climbs — real buying conviction behind this move
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.5x)
●EPS estimates revised upward (+10pts)

VIT Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.2x)
●Moderate revenue growth (+8%)
●Near 52-week low (0% of range)

Ask Scout AI to compare MYX and VIT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
MYX Full Analysis → VIT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).